Leading the advance in regulatory science

Nuala Calnan

doi:10.1007/978-3-642-35161-7_5

Leading the advance in regulatory science

Nuala Calnan

School of Chemical and BioPharmaceutical Science

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

That the pharmaceutical industry is undergoing a period of great transformation can be in little doubt, with so many industry reports highlighting the magnitude of the impact of the patent cliff on big pharma revenues and share prices.

Original language	English
Title of host publication	Leading Pharmaceutical Operational Excellence
Subtitle of host publication	Outstanding Practices and Cases
Publisher	Springer-Verlag Berlin Heidelberg
Pages	59-75
Number of pages	17
ISBN (Electronic)	9783642351617
ISBN (Print)	3642351603, 9783642351600
DOIs	https://doi.org/10.1007/978-3-642-35161-7_5
Publication status	Published - 1 Nov 2013

Access to Document

10.1007/978-3-642-35161-7_5

Cite this

@inbook{f5d65748bc52471a8cb96e55b7ee3ce0,

title = "Leading the advance in regulatory science",

abstract = "That the pharmaceutical industry is undergoing a period of great transformation can be in little doubt, with so many industry reports highlighting the magnitude of the impact of the patent cliff on big pharma revenues and share prices.",

author = "Nuala Calnan",

year = "2013",

month = nov,

day = "1",

doi = "10.1007/978-3-642-35161-7\_5",

language = "English",

isbn = "3642351603",

pages = "59--75",

booktitle = "Leading Pharmaceutical Operational Excellence",

publisher = "Springer-Verlag Berlin Heidelberg",

}

TY - CHAP

T1 - Leading the advance in regulatory science

AU - Calnan, Nuala

PY - 2013/11/1

Y1 - 2013/11/1

N2 - That the pharmaceutical industry is undergoing a period of great transformation can be in little doubt, with so many industry reports highlighting the magnitude of the impact of the patent cliff on big pharma revenues and share prices.

AB - That the pharmaceutical industry is undergoing a period of great transformation can be in little doubt, with so many industry reports highlighting the magnitude of the impact of the patent cliff on big pharma revenues and share prices.

UR - https://www.scopus.com/pages/publications/84929527928

U2 - 10.1007/978-3-642-35161-7_5

DO - 10.1007/978-3-642-35161-7_5

M3 - Chapter

AN - SCOPUS:84929527928

SN - 3642351603

SN - 9783642351600

SP - 59

EP - 75

BT - Leading Pharmaceutical Operational Excellence

PB - Springer-Verlag Berlin Heidelberg

ER -